Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains.
A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
Multiple sclerosis: Defect in peripheral B-cell tolerance identified in MS.
Personalization of multiple sclerosis treatments: using the chelation therapy approach.
Regulation of immune cell infiltration into the CNS by regional neural inputs explained by the gate theory.
Recurrent Guillain-Barré syndrome presenting stereotypic manifestations, positive antiganglioside antibodies, and rapid recovery.
Golli Myelin Basic Proteins Modulate Voltage-Operated Ca(++) Influx and Development in Cortical and Hippocampal Neurons.
Palliative treatment of chronic neurologic disorders.
Exercising away the blues: can it help multiple sclerosis-related depression?
Schwann cells and their transcriptional network: Evolution of key regulators of peripheral myelination.
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases.
Cortical thickness at the time of the initial attack in two patients with paediatric relapsing-remitting multiple sclerosis.
A novel stop mutation in the EDNRB gene in a family with Hirschsprung's disease associated with Multiple Sclerosis.
Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction.
[Reflections on the outcome measures in the clinical trials of multiple sclerosis].
Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions.
Isolation of highly enriched primary human microglia for functional studies.
Minocycline: Far beyond an antibiotic.
Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus.
Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population.
Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring.
FDA reversal sends mixed message to multiple sclerosis community.
[New therapeutic options in multiple sclerosis].
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).

Pages